News | February 05, 2008

Kyron Clinical Imaging Changes Name to Prism Clinical Imaging

February 6, 2008 - Kyron Clinical Imaging Inc. is now Prism Clinical Imaging Inc., a name the company feels better reflects its core mission of providing physicians with treatment planning and management solutions for brain tumors, neurological disorders and other diseases through intuitive organization of imaging data in decks.

The company will appear as its new name at the Prism Workshop at Outpatient Outlook 2008: The Future of Healthcare, to discuss the value of fMRI in clinical application and as an investment to enhance profitability, Feb. 26, 2008 in Tucson, AZ.

For more information: www.prsismclinicalimaging.com

Related Content

Cincinnati Children’s, GE HealthCare
News | Pediatric Imaging
Cincinnati Children’s, GE HealthCare to Collaborate to Drive Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | Radiology Imaging
UCSF, GE HealthCare Launch Joint Research Program to Drive Innovation

Jan. 15, 2025 — University of California, San Francisco (UCSF) Department of Radiology & Biomedical Imaging and GE ...

Time January 27, 2025
arrow
News | Contrast Media
Investigational MRI Contrast Agent Meets Primary and Main Secondary Endpoints in Phase III Studies

Jan. 10, 2025 – Bayer has announced positive topline results of the Phase III QUANTI studies evaluating the efficacy and ...

Time January 14, 2025
arrow
News | Women's Health
GE HealthCare, UC San Diego School of Medicine to Collaborate on Women’s Imaging Research

Aug. 19, 2024 — GE HealthCare recently announced a collaboration with the University of California San Diego School of ...

Time August 29, 2024
arrow
Immunis, Inc. has announced that a partnership with Springbok Analytics to implement their MRI-based AI muscle analysis technology in its Phase 1/2a Clinical Trial, assessing the efficacy of its novel secretome therapeutic (IMMUNA) in targeting sarcopenia.
News | Radiology Business
Immunis Partners with Springbok Analytics on MRI-based AI Muscle Analysis Technology

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
Professional registration is open for RSNA 2024
News | RSNA
RSNA 2024 Registration Is Open

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
GPT-4V, an AI model, often made mistakes when describing the medical image and explaining its reasoning behind the diagnosis—even in cases where it made the correct final choice.
News | Artificial Intelligence
NIH Findings Shed Light on Risks and Benefits of Integrating AI into Medical Decision-making

July 23, 2024 — Researchers at the National Institutes of Health (NIH) found that an artificial intelligence (AI) model ...

Time July 23, 2024
arrow
The total number of Hyperfine AI-powered marketing authorizations places the company in a leading position on recently published FDA list
News | Artificial Intelligence
Hyperfine Announces FDA Clearance of Software Update That Enables Faster Acquisition of Best-in-Class Ultra-Low-Field Brain Images

July 17, 2024 — Hyperfine, a groundbreaking medical device company that has redefined brain imaging with the world’s ...

Time July 17, 2024
arrow
Guidance from preoperative magnetic resonance imaging (MRI) helps clinicians deliver more precise high dose-rate (HDR) prostate brachytherapy treatments
News | Prostate Cancer
GE HealthCare’s MIM Software Introduces MIM Symphony HDR Prostate for MR Image Guidance During Procedures

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
The deployment of DL segmentation methods in 18F-fluciclovine PET/CT imaging represents an intriguing research direction for precision medicine in salvage prostate cancer care
News | Prostate Cancer
Deep Learning-assisted Lesion Segmentation in PET/CT Imaging: A Feasibility Study for Salvage Radiation Therapy in Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now